SYF
81
7
PDCO
38
5
DFS
71
7
D
43
2
NWS
41
2
CCI
31
-5
EFX
44
-6
ADT
46
5
CA
4
-8
AAL
51
9
RF
45
4
WAT
47
-2
ILMN
60
10
V
52
6
NWL
50
3
TROW
34
7
RIG
57
7
TGNA
37
5
NEM
36
2
CSCO
56
2
SYF
81
7
PDCO
38
5
DFS
71
7
D
43
2
NWS
41
2
CCI
31
-5
EFX
44
-6
ADT
46
5
CA
4
-8
AAL
51
9
RF
45
4
WAT
47
-2
ILMN
60
10
V
52
6
NWL
50
3
TROW
34
7
RIG
57
7
TGNA
37
5
NEM
36
2
CSCO
56
2
Financhill
Back

SELLAS Life Sciences Group Quote, Financials, Valuation and Earnings

Invest in This AI Tech Innovator Doubling Revenue

Invest Now!
Sell
47

SLS
SELLAS Life Sciences Group

Last Price:
1.26
Seasonality Move:
3.47%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tech Disruption Wall Street Isn't Talking About...Yet

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

SELLAS Life Sciences Group Price Quote

$1.26

SELLAS Life Sciences Group Key Stats

Sell
47
SELLAS Life Sciences Group (SLS) is a Sell
Day range:
$1.21 - $1.27
52-week range:
$0.50 - $1.72
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
27.83%
Volume:
294.5K
Avg. volume:
435.8K
1-year change:
-14.29%
Market cap:
$81.1M
Revenue:
$0
EPS:
$-0.92

How Much Does SELLAS Life Sciences Group Make?

Data Unavailable

Is SELLAS Life Sciences Group Growing As A Company?

Data Unavailable

SELLAS Life Sciences Group Stock Price Performance

What Is SELLAS Life Sciences Group 52-Week High & Low?

SELLAS Life Sciences Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy SELLAS Life Sciences Group?

Is SELLAS Life Sciences Group Cash Flow Positive?

  • What Is SLS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$32.2M
  • What Is SELLAS Life Sciences Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $30.5M
  • What Is SELLAS Life Sciences Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

SELLAS Life Sciences Group Return On Invested Capital

Data Unavailable

SELLAS Life Sciences Group Earnings Date & Stock Price

SELLAS Life Sciences Group Competitors

SELLAS Life Sciences Group Dividend Yield

SELLAS Life Sciences Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 25%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 5.83
Upside from Last Price: 362.96%

Major Shareholders

  • How many SLS shares are owned by institutional investors?
    6.3M SLS shares are owned by institutional investors
  • How many SLS shares are owned by insiders?
    2.4M SLS shares are owned by insiders